These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37462763)

  • 1. Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy.
    Xiong S; Zhu W; Wu L; Zhou T; Wang W; Zhang O; Xiong X; Liu Z; Luo D
    Cancer Immunol Immunother; 2023 Oct; 72(10):3293-3307. PubMed ID: 37462763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response.
    Tian R; Li Y; Shu M
    Front Immunol; 2021; 12():797450. PubMed ID: 35069579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 5. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
    Liu Y; He X; Yang YI
    J Biosci; 2024; 49():. PubMed ID: 38287674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
    Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
    J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
    Wu J; Zhu Y; Luo M; Li L
    Front Immunol; 2021; 12():748221. PubMed ID: 34659246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer.
    Ling Y; Wang Y; Cao C; Feng L; Zhang B; Li S
    Aging (Albany NY); 2022 Nov; 14(22):9020-9036. PubMed ID: 36384889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between tumor mutation burden and immune infiltration in ovarian cancer.
    Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPRO-related CD8
    Dong H; Xie C; Yao Z; Zhao R; Lin Y; Luo Y; Chen S; Qin Y; Chen Y; Zhang H
    Front Immunol; 2022; 13():947841. PubMed ID: 36003382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
    Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C
    Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
    Xu Q; Chen S; Hu Y; Huang W
    Front Immunol; 2021; 12():711433. PubMed ID: 34512634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.